rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-7-21
|
pubmed:abstractText |
Although no clinical trial data exist on the optimal management of atrial fibrillation (AF) in patients with diastolic heart failure, it has been hypothesized that rhythm-control is more advantageous than rate-control due to the dependence of these patients' left ventricular filling on atrial contraction. We aimed to determine whether patients with AF and heart failure with preserved ejection fraction (EF) survive longer with rhythm versus rate-control strategy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1542-474X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
209-17
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:20645962-Adrenergic beta-Antagonists,
pubmed-meshheading:20645962-Aged,
pubmed-meshheading:20645962-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:20645962-Anti-Arrhythmia Agents,
pubmed-meshheading:20645962-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:20645962-Anticoagulants,
pubmed-meshheading:20645962-Aspirin,
pubmed-meshheading:20645962-Atrial Fibrillation,
pubmed-meshheading:20645962-Calcium Channel Blockers,
pubmed-meshheading:20645962-Digoxin,
pubmed-meshheading:20645962-Diuretics,
pubmed-meshheading:20645962-Female,
pubmed-meshheading:20645962-Heart Failure, Diastolic,
pubmed-meshheading:20645962-Heart Rate,
pubmed-meshheading:20645962-Humans,
pubmed-meshheading:20645962-Kaplan-Meier Estimate,
pubmed-meshheading:20645962-Male,
pubmed-meshheading:20645962-Middle Aged,
pubmed-meshheading:20645962-Proportional Hazards Models,
pubmed-meshheading:20645962-Warfarin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?
|
pubmed:affiliation |
Duke Clinical Research Institute, Durham, NC, USA. mh21@duke.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|